Ophthalmic Eye Drops Franchise in Ahmedabad

Antibiotic Steroid Eye Drops Supplier in Mumbai

Eye Infection Treatment Drops Distributor in Delhi

Ophthalmic Product Manufacturer in Bangalore

Eye Care Medicine Stockist in Hyderabad
Ophthalmic Product Exporter in Chandigarh

Home/Products /moxifloxacin-5-w-v-betamethasone-0-point-1-w-v-eye-ear-drop

About the Product

Description


Moxifloxacin 0.5% + Betamethasone 0.1% Eye Drops are indicated for the management of bacterial eye infections accompanied by inflammation, such as conjunctivitis and postoperative ocular inflammation.

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic that effectively eradicates infection-causing bacteria, while betamethasone, a potent corticosteroid, helps reduce swelling, redness, itching, and ocular discomfort.

This combination is widely prescribed in infective-inflammatory eye conditions where rapid infection control along with inflammation suppression is essential for faster healing and patient comfort.

With reliable clinical performance, quick symptom relief, and wide ophthalmic usage, this formulation supports consistent demand, enhances patient trust, and helps strengthen business growth by addressing routine and recurring eye care needs.


Common side effects may include transient burning sensation, eye irritation, blurred vision, or redness. Rarely, prolonged use may increase intraocular pressure, delayed wound healing, or secondary infections.

Moxolunic B Eye Drop is indicated for steroid-responsive inflammatory ocular conditions with suspected or confirmed bacterial infection, including conjunctivitis, blepharitis, post-operative eye inflammation, and other bacterial eye infections as advised by an ophthalmologist.

For ophthalmic use only. Use strictly under medical supervision. Avoid touching the dropper tip to prevent contamination. Prolonged or improper use may increase the risk of glaucoma or cataract formation. Discontinue use and consult an eye specialist if severe irritation or vision changes occur.

Store below 25°C in a cool, dry place. Protect from light. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Moxifloxacin 0.5% w/v + Betamethasone 0.1% w/v Eye/Ear Drops in the PCD pharma franchise market?

Moxifloxacin 0.5% w/v + Betamethasone 0.1% w/v Eye/Ear Drops have strong demand in the ophthalmology, ENT, and specialty care segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on eye care and ear care portfolios.

Why should medical distributors include Moxifloxacin + Betamethasone Eye/Ear Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management with associated inflammation under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic effective against a wide range of susceptible bacteria Betamethasone 0.1% w/v is a corticosteroid that helps reduce inflammation, redness, swelling, itching, and discomfort Commonly prescribed for bacterial eye infections, post-operative eye care, and selected ear infections accompanied by inflammation, as advised by healthcare professionals Helps address both infection and inflammatory symptoms through a dual-action approach Sterile eye/ear drop formulation allows targeted local administration Frequently used in ophthalmology clinics, ENT practices, hospitals, and surgical care settings Widely prescribed by ophthalmologists, ENT specialists, and healthcare professionals This strengthens a comprehensive ophthalmology and ENT care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Betamethasone 0.1% w/v Eye/Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, steady retail and institutional sales, repeat purchases, reliable supply chain support, and attractive margins in the ophthalmic and ENT segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.